Yon Ko

4.4k citations

69 papers · 3.1k indexed · 1 hit paper · h-index 31

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Mesenchymal stem cell research

Papers in ⓘ

Applied Microbiology and Biotechnology 2
Cancer Research 14
- Protease and Inhibitor Mechanisms 5

Co-authors: Agapios Sachinidis (40 shared papers)H. Vetter (39 shared papers)Thomas J. Neuhaus (11 shared papers)Sebastian Stier (10 shared papers)Claudia Seul (16 shared papers)Elisabeth Grünewald (5 shared papers)Ioanna Gouni‐Berthold (10 shared papers)Susan R. Rittling (2 shared papers)
Journals: British Journal of Pharmacology (5 papers)Journal of Hypertension (4 papers)FEBS Letters (4 papers)Hypertension (4 papers)Journal of Molecular Medicine (3 papers)
Partner nations: Germany United States South Korea

In The Last Decade

Yon Ko

68 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size 2005 · 523 citations

Peers

Countries citing papers authored by Yon Ko

Since Specialization

Citations

This map shows the geographic impact of Yon Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yon Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yon Ko more than expected).

Fields of papers citing papers by Yon Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yon Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yon Ko. The network helps show where Yon Ko may publish in the future.

Co-authors

The 25 scholars most cited alongside Yon Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yon Ko Line = papers co-authored together Yon Ko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size The Journal of Experimental Medicine ·Sebastian Stier, Yon Ko, Randolf Forkert, Christoph Lutz, Thomas J. Neuhaus, Elisabeth Grünewald, Tao Cheng, David Dombkowski, Laura M. Calvi, Susan R. Rittling, David T. Scadden Hit paper breakdown →	2005	523
2	Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera Cancer Cell ·Gerlinde Wernig, Michael G. Kharas, Rachel Okabe, Sandra Moore, Dena S. Leeman, Dana E. Cullen, Maricel Gozo, Elizabeth McDowell, Ross L. Levine, John Doukas, Chi Ching Mak, Glenn Noronha, Michael Martin, Yon Ko, Benjamin H. Lee, Richard Söll, Ayalew Tefferi, John Hood, D. Gary Gilliland	2008	305
3	Markers of genetic susceptibility in human environmental hygiene and toxicology: The role of selected CYP, NAT and GST genes International Journal of Hygiene and Environmental Health ·Ricarda Thier, Thomas Brüning, P. Roos, Hans‐Peter Rihs, Klaus Golka, Yon Ko, Hermann M. Bolt	2003	135
4	Thromboxane A₂and Vascular Smooth Muscle Cell Proliferation Hypertension ·Agapios Sachinidis, Markus Flesch, Yon Ko, Karsten Schrör, Michael Böhm, Rainer Düsing, H. Vetter	1995	125
5	Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care Supportive Care in Cancer ·Sven Simons, Susanne Ringsdorf, Michael Braun, Ulrich Mey, P Schwindt, Yon Ko, Ingo Schmidt‐Wolf, Walther Kuhn, Ulrich Jaehde	2010	108
6	Night work and breast cancer – results from the German GENICA study Scandinavian Journal of Work Environment & Health ·Beate Pesch, Volker Harth, Sylvia Rabstein, Christian Baisch, Markus Schiffermann, Dirk Pallapies, Nadine Bonberg, Evelyn Heinze, Anne Spickenheuer, Christina Justenhoven, Hiltrud Brauch, Ute Hamann, Yon Ko, Kurt Straíf, Thomas Brüning	2009	104
7	Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma FEBS Letters ·Agapios Sachinidis, Claudia Seul, Stefan Seewald, Hee-Yul Ahn, Yon Ko, H. Vetter	2000	81
8	Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. PubMed ·Yon Ko, Michael Klinz, Gudrun Totzke, Ioanna Gouni‐Berthold, Agapios Sachinidis, H. Vetter	1998	72
9	Evidence That Lipoproteins Are Carriers of Bioactive Factors Arteriosclerosis Thrombosis and Vascular Biology ·Agapios Sachinidis, Ralf Kettenhofen, Stefan Seewald, Ioanna Gouni‐Berthold, Udo K. Schmitz, Claudia Seul, Yon Ko, H. Vetter	1999	72
10	Mechanisms of the inhibitory effects of epigallocatechin‐3 gallate on platelet‐derived growth factor‐BB‐induced cell signaling and mitogenesis The FASEB Journal ·Artur‐Aron Weber, Thomas J. Neuhaus, Romanita Adriana Skach, Jürgen Hescheler, Hee‐Yul Ahn, Karsten Schrör, Yon Ko, Agapios Sachinidis	2003	71
11	One-Carbon Metabolism and Breast Cancer Risk: No Association ofMTHFR, MTR, andTYMSPolymorphisms in the GENICA Study from Germany Cancer Epidemiology Biomarkers & Prevention ·Christina Justenhoven, Ute Hamann, Christiane Barbara Pierl, Sylvia Rabstein, Beate Pesch, Volker Harth, Christian Baisch, Caren Vollmert, Thomas Illig, Brüning Thomas, Yon Ko, Hiltrud Brauch	2005	66
12	Stromal cell‐derived factor 1α (SDF‐1α) induces gene‐expression of early growth response‐1 (Egr‐1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation Cell Proliferation ·Thomas J. Neuhaus, Sebastian Stier, Gudrun Totzke, Elisabeth Gruenewald, Stefan Fronhoffs, Agapios Sachinidis, H. Vetter, Yon Ko	2003	63
13	Human endothelial cells selectively express large amounts of pancreatic‐type ribonuclease (RNase 1) Journal of Cellular Biochemistry ·Julien Landré, Peter W. Hewett, Jean‐Marc Olivot, Peter Friedl, Yon Ko, Agapios Sachinidis, Michel Moenner	2002	61
14	Differential Gene Expression in Synovium of Rheumatoid Arthritis and Osteoarthritis PubMed ·Hans‐Peter Jüsten, Elisabeth Grünewald, Gudrun Totzke, Ioanna Gouni‐Berthold, Agapios Sachinidis, D. Wessinghage, H. Vetter, Klaus Schulze‐Osthoff, Yon Ko	2000	59
15	Inhibition of the platelet‐derived growth factor β‐receptor tyrosine‐phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins The FASEB Journal ·Agapios Sachinidis, Romanita Adriana Skach, Claudia Seul, Yon Ko, Jürgen Hescheler, Hee‐Yul Ahn, Jürgen Fingerle	2002	58
16	Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas International Journal of Cancer ·Susanne Haas, Christiane Barbara Pierl, Volker Harth, Beate Pesch, Sylvia Rabstein, Thomas Brüning, Yon Ko, Ute Hamann, Christina Justenhoven, Hiltrud Brauch, Hans‐Peter Fischer	2006	56
17	Chronic liver disease in heterozygous α1-antitrypsin deficiency PiZ Journal of Hepatology ·Hans‐Peter Fischer, M.Elena Ortiz-Pallardó, Yon Ko, Christiane Esch, Hui Zhou	2000	54
18	Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development Pharmacogenetics ·Ji‐Yeob Choi, Josef Abel, Thomas J. Neuhaus, Yon Ko, Volker Harth, Nobuyuki Hamajima, Kazuo Tajima, Keun-Young Yoo, Sue K. Park, Dong‐Young Noh, Wonshik Han, Kuk‐Jin Choe, Sei-Hyun Ahn, Sook-Un Kim, Ari Hirvonen, Daehee Kang	2003	53
19	Eukaryotic Initiation Factor 3 p110 mRNA Is Overexpressed in Testicular Seminomas American Journal Of Pathology ·Marcus Rothe, Yon Ko, Peter Albers, Nicolas Wernert	2000	52
20	Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: A randomized trial in healthy men Atherosclerosis ·Ioanna Gouni‐Berthold, Heiner K. Berthold, Helena Gylling, Maarit Hallikainen, Eleni Giannakidou, Sebastian Stier, Yon Ko, Dilip Patel, Anne K. Soutar, Udo Seedorf, Christos S. Mantzoros, Jogchum Plat, Wilhelm Krone	2007	51

About Yon Ko

Yon Ko is a scholar working on Applied Microbiology and Biotechnology, Cancer Research, Molecular Biology, Hematology and Pathology and Forensic Medicine, having authored 69 papers that have together received 3.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Angiogenesis and VEGF in Cancer (6 papers), Glutathione Transferases and Polymorphisms (6 papers), Protease and Inhibitor Mechanisms (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Estrogen and related hormone effects (4 papers) and Renin-Angiotensin System Studies (4 papers). The work is most often cited by research in Hematology (591 citations), Genetics (493 citations), Family Practice (70 citations), Applied Microbiology and Biotechnology (56 citations) and Cancer Research (389 citations). Yon Ko has collaborated with scholars based in Germany, United States and South Korea. Frequent co-authors include Agapios Sachinidis, H. Vetter, Thomas J. Neuhaus, Sebastian Stier, Claudia Seul, Elisabeth Grünewald, Ioanna Gouni‐Berthold, Susan R. Rittling, Christoph Lutz and David Dombkowski. Their work appears in journals such as British Journal of Pharmacology, Journal of Hypertension, FEBS Letters, Hypertension and Journal of Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact